| 000 | 01632 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517081517.0 | ||
| 264 | 0 | _c20161213 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1745-6215 | ||
| 024 | 7 |
_a10.1186/s13063-016-1220-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSommerer, Claudia | |
| 245 | 0 | 0 |
_aDesign and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. _h[electronic resource] |
| 260 |
_bTrials _cFeb 2016 |
||
| 300 |
_a92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aClinical Protocols |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 |
_aEverolimus _xadministration & dosage |
| 650 | 0 | 4 | _aGraft Rejection |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Failure |
| 700 | 1 | _aSuwelack, Barbara | |
| 700 | 1 | _aDragun, Duska | |
| 700 | 1 | _aSchenker, Peter | |
| 700 | 1 | _aHauser, Ingeborg A | |
| 700 | 1 | _aNashan, Björn | |
| 700 | 1 | _aThaiss, Friedrich | |
| 773 | 0 |
_tTrials _gvol. 17 _gp. 92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13063-016-1220-9 _zAvailable from publisher's website |
| 999 |
_c25743749 _d25743749 |
||